Cargando…

Cebranopadol as a Novel Promising Agent for the Treatment of Pain

Opioids are used to treat pain, but despite their effectiveness, they possess several side effects such as respiratory depression, tolerance and physical dependence. Cebranopadol has been evaluated as a solution to this problem. The compound acts on the mu opioid receptor and the nociceptin/orphanin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ziemichod, Wojciech, Kotlinska, Jolanta, Gibula-Tarlowska, Ewa, Karkoszka, Natalia, Kedzierska, Ewa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268744/ https://www.ncbi.nlm.nih.gov/pubmed/35807228 http://dx.doi.org/10.3390/molecules27133987

Ejemplares similares

Crosstalk between Opioid and Anti-Opioid Systems: An Overview and Its Possible Therapeutic Significance
por: Gibula-Tarlowska, Ewa, et al.
Publicado: (2020)

Deleterious Effects of Ethanol, Δ(9)-Tetrahydrocannabinol (THC), and Their Combination on the Spatial Memory and Cognitive Flexibility in Adolescent and Adult Male Rats in the Barnes Maze Task
por: Gibula-Tarlowska, Ewa, et al.
Publicado: (2020)

Aversive Learning Deficits and Depressive-Like Behaviors Are Accompanied by an Increase in Oxidative Stress in a Rat Model of Fetal Alcohol Spectrum Disorders: The Protective Effect of Rapamycin
por: Lopatynska-Mazurek, Malgorzata, et al.
Publicado: (2021)

Rapamycin Improves Recognition Memory and Normalizes Amino-Acids and Amines Levels in the Hippocampal Dentate Gyrus in Adult Rats Exposed to Ethanol during the Neonatal Period
por: Lopatynska-Mazurek, Malgorzata, et al.
Publicado: (2021)

Impact of Mephedrone on Fear Memory in Adolescent Rats: Involvement of Matrix Metalloproteinase-9 (MMP-9) and N-Methyl-D-aspartate (NMDA) Receptor
por: Grochecki, Pawel, et al.
Publicado: (2023)

Alteration of Ethanol Reward by Prior Mephedrone Exposure: The Role of Age and Matrix Metalloproteinase-9 (MMP-9)
por: Grochecki, Pawel, et al.
Publicado: (2022)

Rapamycin Improves Spatial Learning Deficits, Vulnerability to Alcohol Addiction and Altered Expression of the GluN2B Subunit of the NMDA Receptor in Adult Rats Exposed to Ethanol during the Neonatal Period
por: Lopatynska-Mazurek, Malgorzata, et al.
Publicado: (2021)

Effects of the Positive Allosteric Modulator of Metabotropic Glutamate Receptor 5, VU-29, on Maintenance Association between Environmental Cues and Rewarding Properties of Ethanol in Rats
por: Marszalek-Grabska, Marta, et al.
Publicado: (2020)

Hemorphins—From Discovery to Functions and Pharmacology
por: Mielczarek, Przemyslaw, et al.
Publicado: (2021)

Assessment of spatial learning and memory in the Barnes maze task in rodents—methodological consideration
por: Gawel, Kinga, et al.
Publicado: (2018)

Effects of Mephedrone and Amphetamine Exposure during Adolescence on Spatial Memory in Adulthood: Behavioral and Neurochemical Analysis
por: Grochecki, Pawel, et al.
Publicado: (2021)

Cebranopadol: A First-in-Class Nociceptin Receptor Agonist for Managing Chronic Pain
por: Nair, Abhijit S, et al.
Publicado: (2020)

Clinical Pharmacokinetic Characteristics of Cebranopadol, a Novel First-in-Class Analgesic
por: Kleideiter, Elke, et al.
Publicado: (2017)

Effects of the Positive Allosteric Modulator of Metabotropic Glutamate Receptor 5, VU-29, on Impairment of Novel Object Recognition Induced by Acute Ethanol and Ethanol Withdrawal in Rats
por: Marszalek-Grabska, Marta, et al.
Publicado: (2018)

Correction to: Clinical Pharmacokinetic Characteristics of Cebranopadol, a Novel First-in-Class Analgesic
por: Kleideiter, Elke, et al.
Publicado: (2018)

Synthesis, Docking Studies and Pharmacological Evaluation of Serotoninergic Ligands Containing a 5-Norbornene-2-Carboxamide Nucleus
por: Sparaco, Rosa, et al.
Publicado: (2022)

Effects of Cebranopadol on Cocaine-induced Hyperactivity and Cocaine Pharmacokinetics in Rats
por: Wei, Huimei, et al.
Publicado: (2020)

Characteristics of Seltorexant—Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety
por: Ziemichód, Wojciech, et al.
Publicado: (2023)

A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism
por: Fantinati, Anna, et al.
Publicado: (2017)

Synergistic Action of Sodium Selenite with some Antidepressants and Diazepam in Mice
por: Kędzierska, Ewa, et al.
Publicado: (2018)

Cholinesterase inhibitors, donepezil and rivastigmine, attenuate spatial memory and cognitive flexibility impairment induced by acute ethanol in the Barnes maze task in rats
por: Gawel, Kinga, et al.
Publicado: (2016)

Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist
por: Rizzi, Anna, et al.
Publicado: (2016)

Cebranopadol, a novel first-in-class analgesic drug candidate: first experience in patients with chronic low back pain in a randomized clinical trial
por: Christoph, Annette, et al.
Publicado: (2017)

The Occurrence and Biological Activity of Tormentic Acid—A Review
por: Olech, Marta, et al.
Publicado: (2021)

A Comprehensive Review of Daridorexant, a Dual-Orexin Receptor Antagonist as New Approach for the Treatment of Insomnia
por: Ziemichód, Wojciech, et al.
Publicado: (2022)

Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled Study
por: Göhler, Karin, et al.
Publicado: (2019)

Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain
por: Sałat, Kinga, et al.
Publicado: (2017)

Recent Studies on the Development of Nicotine Abuse and Behavioral Changes Induced by Chronic Stress Depending on Gender
por: Grabowska, Karolina, et al.
Publicado: (2023)

5,8-Quinolinedione Scaffold as a Promising Moiety of Bioactive Agents
por: Kadela-Tomanek, Monika, et al.
Publicado: (2019)

Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors
por: Shen, Qianwei, et al.
Publicado: (2017)

IRE1α Inhibitors as a Promising Therapeutic Strategy in Blood Malignancies
por: Wiese, Wojciech, et al.
Publicado: (2022)

Mouse single oocyte imaging by MALDI-TOF MS for lipidomics
por: Bodzon-Kulakowska, Anna, et al.
Publicado: (2020)

Synergistic interaction between the agonism of cebranopadol at nociceptin/orphanin FQ and classical opioid receptors in the rat spinal nerve ligation model
por: Christoph, Thomas, et al.
Publicado: (2018)

The Role of Diet as a Modulator of the Inflammatory Process in the Neurological Diseases
por: Kurowska, Antonina, et al.
Publicado: (2023)

Clinically significant drug–drug interactions involving opioid analgesics used for pain treatment in patients with cancer: a systematic review
por: Kotlinska-Lemieszek, Aleksandra, et al.
Publicado: (2015)

Natural Compounds as Promising Adjuvant Agents in The Treatment of Gliomas
por: Persano, Francesca, et al.
Publicado: (2022)

5-HT(2C) Receptor Stimulation in Obesity Treatment: Orthosteric Agonists vs. Allosteric Modulators
por: Przegaliński, Edmund, et al.
Publicado: (2023)

Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
por: Giacoppo, Sabrina, et al.
Publicado: (2014)

Promising oncolytic agents for metastatic breast cancer treatment
por: Cody, James J, et al.
Publicado: (2015)

Virtual Reality as a Promising Tool Supporting Oncological Treatment in Breast Cancer
por: Zasadzka, Ewa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_doetbl763c2iabacqlmc3qfcs3